New study: probiotics and allergic rhinitis

Improving quality of life of patients with allergic rhinitis

Worldwide, the prevalence of allergic diseases is rising dramatically in both developed and developing countries. Allergic diseases are caused by hypersensitivity of the immune system to harmful substances in the environment.

Major allergic diseases include asthma, food allergies, allergic rhinitis (AR) and atopic dermatitis (AD) or eczema. Worldwide, AR currently affects between 10% and 30% of the population and studies indicate that prevalence rates are increasing. It is not completely clear what triggers the dramatic increases in incidence of allergies, but many theories postulate the involvement of (Westernized) lifestyle, environment and (missing) microbes.

With this knowledge, Winclvoe has developed the probiotic formulation Ecologic® ALLERGYCARE for management of allergic symptoms. The formulation has proven in a previous study to significantly reduce atopic dermatitis. In a recently finished study the formulation showed to singificantly improve quality of life in patients with allergic rhinitis. publication of the study results is expected, the manuscript of the study protocol has been published in the Journal of Alternative and Complementary Medicine.


Mixture of bacterial strains:

B. bifidum W23

L. acidophilus W55

L. casei W56

L. salivarius W57

Lc. lactis W58


Other ingredients:

Vitamin B2


PROBIOACT® Technology: protective and nutritional ingredients that improve the effectiveness of the formulation.

Interesting updates in your mailbox

Subscribe to our newsletter and receive the latest news about Winclove, probiotic-related research & publications, relevant market developments and inspiring articles.

Also interesting


Mind, Mood & Microbes covers multiple scientific perspectives on the microbiota-gut-brain axis


New study provides support for Ecologic Allergycare to improve quality of life in allergic rhinitis patients


Exploring the benefits of probiotics in cognitive function